Ibrexafungerp, a Novel Triterpenoid Antifungal in Development for the Treatment of Mold Infections
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Fungi"
DOI: 10.3390/jof8111121
Abstract: Molds are ubiquitous in the environment, and immunocompromised patients are at substantial risk of morbidity and mortality due to their underlying disease and the resistance of pathogenic molds to currently recommended antifungal therapies. This combination… read more here.
Keywords: invasive mold; mold infections; ibrexafungerp novel; fungal infections ... See more keywords